{"DataElement":{"publicId":"3762328","version":"1","preferredName":"Breast Carcinoma In Situ Cellularity Percentage Value","preferredDefinition":"Numeric entry to represent the estimated percent of the final primary tumor bed that contains In Situ cancer that is different from the options given.","longName":"3198794v1.0:3028685v1.0","context":"BOLD","contextVersion":"1","DataElementConcept":{"publicId":"3198794","version":"1","preferredName":"Ductal Breast Carcinoma In Situ Present","preferredDefinition":"information related to presence of ductal carcinoma in situ (DCIS) is a carcinoma entirely confined to the mammary ducts.","longName":"2413053v1.0:2177376v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2413053","version":"1","preferredName":"DCIS","preferredDefinition":"Ductal carcinoma in situ (DCIS) is a carcinoma entirely confined to the mammary ducts.  There is no evidence of invasion of the basement membrane.  Currently, DCIS is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis.  The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS. --2002","longName":"C2924","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"01D4D496-BCED-3A9F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-30","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-09-30","modifiedBy":"ONEDATA","dateModified":"2005-09-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177376","version":"1","preferredName":"Present","preferredDefinition":"Present; the period of time that is happening now.","longName":"Present","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-5263-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D984671-1F50-971F-E040-BB89AD435628","latestVersionIndicator":"Yes","beginDate":"2011-03-03","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-03-03","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3028685","version":"1","preferredName":"Cell Characteristic Percentage Value","preferredDefinition":"values for the percentage for measurement of a trait of a specimen of tumor or other tissue._The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid._The distinguishing qualities or prominent aspect of a person, object, action, process, or substance._Percentage; a fraction or ratio with 100 understood as the denominator.","longName":"CELL_CHAR_PCT_VAL","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"%","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2178079","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"EDRN","contextVersion":"1","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"CC049DE1-E986-5FB4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3028684","version":"1","preferredName":"Cell Characteristic Percentage Value","preferredDefinition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.:Characteristics; distinguishing qualities of a person, object, or substance.:Percentage; a fraction or ratio with 100 understood as the denominator.:Value; a numerical quantity measured or assigned or computed.","longName":"C12508:C25447:C25613:CL052797","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cell","conceptCode":"C12508","definition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Characteristic","conceptCode":"C25447","definition":"The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"CL052797","definition":"Value; a numerical quantity measured or assigned or computed.","evsSource":"NCI_META_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"825FF8E4-2232-6783-E040-BB89AD43233B","latestVersionIndicator":"Yes","beginDate":"2010-03-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-22","modifiedBy":"ONEDATA","dateModified":"2010-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"825FF8E4-2243-6783-E040-BB89AD43233B","latestVersionIndicator":"Yes","beginDate":"2010-03-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-22","modifiedBy":"ONEDATA","dateModified":"2010-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3461586","version":"1","longName":"BOLD:Breast Oncology Local Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461587","version":"1","longName":"Preoperative Elements","context":"NCIP"}]},{"publicId":"3886755","version":"1","longName":"Preoperative Elements","context":"BOLD","ClassificationSchemeItems":[{"publicId":"3902140","version":"1","longName":"Preoperative","context":"BOLD"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Other (%)","type":"Preferred Question Text","description":"Other (%)","url":null,"context":"NCIP"}],"origin":"BOLD:Breast Oncology Local Disease Initiative","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"DCC460A2-D239-D946-E040-BB89AD432A72","latestVersionIndicator":"Yes","beginDate":"2013-05-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-15","modifiedBy":"REEVESD","dateModified":"2016-09-06","changeDescription":"Curated to support Breast Oncology Local Disease (BOLD) Initiative","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}